SALT LAKE CITY, Jan. 9, 2012 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s health company developing diagnostic tests for early prediction of preterm birth and other pregnancy complications, today announced the appointment of Jay Boniface, Ph.D., as Vice President of Research & Development. Dr. Boniface will lead the discovery, translation and development activities for Sera’s preterm birth predictor and other products the company is pursuing in maternal-fetal medicine.